Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaka Kranjc

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biotechnology Progress|May 21, 2026
β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profilesJaka Kranjc, Stane Pajk, Marko Anderluh, et al.
Chemmedchem|December 23, 2024
New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual ScreeningJaka Kranjc, Tihomir Tomašič, Stane Pajk, et al.
Frontiers in Bioengineering and Biotechnology|September 10, 2024
Modulating antibody N-glycosylation through feed additives using a multi-tiered approachJaka Kranjc, Lovro Kramer, Miha Mikelj, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biotechnology Progress|May 21, 2026
β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profilesJaka Kranjc, Stane Pajk, Marko Anderluh, et al.
Chemmedchem|December 23, 2024
New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual ScreeningJaka Kranjc, Tihomir Tomašič, Stane Pajk, et al.
Frontiers in Bioengineering and Biotechnology|September 10, 2024
Modulating antibody N-glycosylation through feed additives using a multi-tiered approachJaka Kranjc, Lovro Kramer, Miha Mikelj, et al.
Pageof 1